Table 1 Baseline information of the patients (n = 63) with vertebral and basilar artery aneurysms treated with stent-assisted coil embolization using LVIS device
Characteristics | No. (%) |
|---|---|
Mean age (years) (mean ± SD) | 52.2 ± 10.9 |
Gender | |
Women | 19 (30.2) |
Men | 44(69.8) |
Main symptoms | |
Chronic Headache/dizziness | 25 (39.7) |
Neurological deficits | 17 (27.0) |
Incidental | 11 (17.5) |
Acute SAH | 10 (15.9) |
Risk factors | |
Smoking | 24 (38.1) |
DM | 5 (7.9) |
Hyperlipidemia | 6 (9.5) |
HBP | 33 (52.4) |
Pre-operative mRS scale (n = 63) | |
0 | 27 (42.9) |
1 | 23 (36.5) |
2 | 3 (4.8) |
3 | 7 (11.1) |
4 | 3 (4.8) |
Clinical follow-up available | 62 (98.4) |
mRS scale at lasted follow up (n = 42) | |
0 | 38 (61.3) |
1 | 21 (33.9) |
2 | 0 (0.0) |
3 | 1 (1.6) |
4 | 1 (1.6) |
5 | 0 (0.0) |
6 | 1 (1.6)a |
Follow-up period (months) (mean ± SD (range)) | 24.3 ± 10.6 (12–38) |